Practical synthesis of a p38 MAP kinase inhibitor

Michał Achmatowicz1, Oliver R Thiel, Philip Wheeler

  • 1Chemical Process Research and Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, USA. michala@amgen.com

Summary

Researchers developed a practical synthesis for a p38 MAP kinase inhibitor using a phthalazine scaffold. This efficient method aids in creating potential treatments for inflammatory diseases.